EN
HI
Glenmark Pharmaceuticals share price chart
Glenmark Pharmaceuticals Share Key Metrics
Volume
2.75 L
Market Cap
63198.87 CR
LTQ@LTP
15@2242.10
ATP
2235.83
Var Margin
15.33 %
Circuit Range
2015.6-2463.4
Delivery %
64.12 %
Value
61.43 CR
ASM/GSM
No
Market Lot
1
Summary
GLENMARK stock price is ₹2242.1 as of 22 Jul, 2026. The stock intraday movement has stayed between ₹2221.10 and ₹2249.30, while Glenmark Pharmaceuticals share price 52 week high low is ₹1792.60 & ₹2474.00.
In terms of trading activity, GLENMARK share price has recorded a volume of 2,74,753 shares. The Glenmark Pharmaceuticals has a market cap of ₹282200809. The stock’s Average Traded Price (ATP) stands at ₹2235.83, while the Last Traded Quantity at Last Traded Price (LTQ@LTP) is 15 @ ₹2242.10.
The Glenmark Pharmaceuticals upper circuit limit is ₹2463.40 & The Glenmark Pharmaceuticals lower circuit limit is ₹2015.60, with a Value of ₹61.43 CR. The Delivery Percentage for the day is 64.12%.
Additionally, the share currently falls under the No framework, and trades with a market lot size of ₹1.
Glenmark Pharmaceuticals Fundamentals
P/E Ratio
46.4
P/B Ratio
6.01
Div. Yield
0.11
Sector P/E
69.79
Sector P/B
3.29
Sec. Div. Yield
0.53
Glenmark Pharmaceuticals Resistance and Support
Pivot 2244.93
Resistance
First Resistance
2264.56
Second Resistance
2289.63
Third Resistance
2309.26
Support
First Support
2219.86
Second Support
2200.23
Third Support
2175.16
Glenmark Pharmaceuticals Futures & Options
Glenmark Pharmaceuticals Option Chain
View Price, OI, Greeks & More...
28JUL26
2247.00
0.40 (0.02%)
25AUG26
2260.30
1.80 (0.08%)
29SEP26
2263.00
4.40 (0.19%)
GLENMARK|28JUL26 CE 2240.00
36.00
-4.05 (-10.11%)
GLENMARK|28JUL26 PE 2260.00
39.75
-3.95 (-9.04%)
Glenmark Pharmaceuticals Corporate Actions
| Date | Agenda |
|---|---|
| 2026-07-31 | Quarterly Results |
| 2026-05-29 | Audited Results & Final Dividend |
| 2026-01-30 | Quarterly Results |
| 2025-11-14 | Quarterly Results |
| 2025-09-26 | Interim Dividend |
| 2025-08-14 | Quarterly Results |
| 2025-05-23 | Audited Results & Final Dividend |
| 2025-02-14 | Quarterly Results |
| 2024-11-14 | Quarterly Results |
| 2024-08-14 | Quarterly Results |
Glenmark Pharmaceuticals News
Glenmark Pharmaceuticals Ltd - 532296 - Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation
Glenmark Pharmaceuticals has scheduled an earnings call on August 3, 2026, from 8:30 AM to 9:30 AM IST. The call will discuss the company's unaudited financial results for the first quarter of FY27 (ended June 30, 2026).
Jul 21 2026 15:20:12
Glenmark Pharmaceuticals Ltd - 532296 - Announcement under Regulation 30 (LODR)-Press Release / Media Release
Glenmark Specialty S.A. (Glenmark) received U.S. FDA approval for expanded use of RYALTRIS® Nasal Spray for treating seasonal allergic rhinitis in pediatric patients aged 6 to under 12 years. This approval strengthens Glenmark's US respiratory portfolio.
Jul 21 2026 08:43:01
Read More
Glenmark Pharmaceuticals Management
| Name | Position |
|---|---|
| Rashmi Khandelwal | Company Secretary & Compliance Officer |
| Glenn Saldanha | Chairman & Managing Director |
Glenmark Pharmaceuticals Similar Stocks
Glenmark Pharmaceuticals FAQs
The Buying Price of Glenmark Pharmaceuticals share is 2242.1 For live prices and instant trading, you can log in to your Choice trading account or open a Free Demat account with Choice.
To buy Glenmark Pharmaceuticals stocks, log in to your Choice trading account. If you don’t have one, open a Choice Demat account. Then, add funds, search for Glenmark Pharmaceuticals, choose your preferred order type, and place the trade.
The Price-to-earnings (P/E) ratio of Glenmark Pharmaceuticals shares is 46.4. You can compare it with the sector average for relative valuation.
The Price to Book (P/B) ratio Glenmark Pharmaceuticals shares is 6.01. Useful to assess the stock's value relative to its book value.
To assess Glenmark Pharmaceuticals’s valuation compare Sector P/E, P/B which are 69.79 & 3.29 with sector averages, along with growth rates and financial metrics.
The Market Cap of Glenmark Pharmaceuticals is 63198.87 CR. It indicates the company's size category and trading liquidity.
The 52 week high and low prices of Glenmark Pharmaceuticals share price is 2474.00 & 1792.60. They indicate price extremes, trading ranges, volatility measures, potential support/resistance, and price momentum.
Glenmark Pharmaceuticals belongs to the Healthcare sector.
Open a FREE Demat Account in 5 Mins.
AMC for First Year- Auto Square Off Charges
13 Lakh+ Clients
Expert-Backed
Premium Tools
